Highest return-on-assets companies
Companies ranked by trailing return on assets (ROA) — how efficiently a business turns its asset base into profit. Delayed fundamentals from market data, shown with their as-of date.
Ranked by ROA: companies 2,901–2,925 of 3,067.
| # | Company | Sector | ROA | Net margin | Market cap |
|---|---|---|---|---|---|
| 2901 | Vanda Pharmaceuticals Inc (VNDA) | Health Care | -45.1% | -102.0% | $231M |
| 2902 | Critical Metals Corp (CRML) | Materials | -45.3% | n/a | $864M |
| 2903 | Veradermics Incorporated (MANE) | Health Care | -45.9% | n/a | $5.8B |
| 2904 | Orchestra BioMed Holdings Inc (OBIO) | Health Care | -45.9% | -157.4% | $341M |
| 2905 | Allogene Therapeutics Inc (ALLO) | Health Care | -45.9% | n/a | $359M |
| 2906 | Vista Gold Corp (VGZ) | Materials | -46.1% | n/a | $401M |
| 2907 | Owlet, Inc. (OWLT) | Health Care | -46.3% | -37.5% | $122M |
| 2908 | Corbus Pharmaceuticals Holdings in (CRBP) | Health Care | -46.7% | n/a | $59M |
| 2909 | MeiraGTx Holdings plc (MGTX) | Health Care | -46.7% | -140.3% | $864M |
| 2910 | Savara Inc (SVRA) | Health Care | -46.9% | n/a | $992M |
| 2911 | Aldeyra Therapeutics, Inc. (ALDX) | Health Care | -47.0% | n/a | $38M |
| 2912 | Zentalis Pharmaceuticals Inc (ZNTL) | Health Care | -47.4% | n/a | $123M |
| 2913 | Voyager Therapeutics Inc (VYGR) | Health Care | -47.5% | -296.5% | $116M |
| 2914 | Revolution Medicines (RVMD) | Health Care | -48.0% | n/a | $41.6B |
| 2915 | Bumble Inc Class A (BMBL) | Communication Services | -48.6% | -71.8% | $788M |
| 2916 | Alector Inc (ALEC) | Health Care | -48.7% | -679.2% | $341M |
| 2917 | Innventure Inc (INV) | Financials | -49.0% | -14266.4% | $12M |
| 2918 | Intellia Therapeutics Inc (NTLA) | Health Care | -49.0% | -609.9% | $1.6B |
| 2919 | Cullinan Therapeutics Inc (CGEM) | Health Care | -49.0% | n/a | $728M |
| 2920 | Simulations Plus Inc (SLP) | Health Care | -49.1% | -81.7% | $374M |
| 2921 | Aardvark Therapeutics, Inc. (AARD) | Health Care | -49.1% | n/a | $26M |
| 2922 | ArriVent BioPharma Inc (AVBP) | Health Care | -49.9% | n/a | $673M |
| 2923 | Atea Pharmaceuticals Inc (AVIR) | Health Care | -50.2% | 34.5% | $346M |
| 2924 | Viking Therapeutics (VKTX) | Health Care | -50.2% | n/a | $3.4B |
| 2925 | Tenax Therapeutics Inc (TENX) | Health Care | -50.5% | n/a | $63M |
Find more highest return-on-assets companies like these →
Data: SEC EDGAR (filings) + market data (fundamentals, delayed daily-close). Every figure is shown with its as-of date on the company page; a company with no data for this metric is excluded from the ranking, never estimated.
Last updated 2026-11-06 — rankings shift as the underlying data refreshes.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date.